Ecg Watch looks like a common wristwatch, but able to detect an electrocardiogram, which can be viewed on smartphone and shared with the cardiology service center. There are no adhesive contacts or wires and the analysis can be performed even when standing up, without the need to undress. The App available on Smartphones displays the ECG, and is able to detect both the heart rate and atrial fibrillation.
In Italy, the direct healthcare costs for cardiovascular diseases have been estimated at approximately €16 billion, to which must be added €5 billion incurred in terms
of indirect costs calculated as loss of productivity.
The chosen entry market is that of Piedmont, where 34,000 people die each year
from cardiovascular diseases; the clinical trials will be carried out with the various
Piedmont hospitals, which have already approved telemedicine.
Current technologies limits / Solutions
Current technologies are either inaccurate or require advanced medical equipment to monitor patient health; in addition, portable solutions are typically not wearable. However, all the market available solutions require a certain degree of medical expertise to be used correctly.
The first application of the proposed technology is a non-invasive cuffless blood pressure monitor (see PoC project). The proposed technology can also acquire an electrocardiogram and monitoring heart rate and blood oxygenation; therefore, thanks to the artificial intelligence algorithms and the smartphone-based approach, the proposed device can be used as a wearable COVID-19 symptom detector connected with hospitals, even at a distance of hundreds of kilometers.
Technology and our solution
A wrist wearable device with specific sensors for acquiring various vital parameters regarding the heart health. The data acquired by the smart watch is sent to a smartphone app, which, using innovative artificial intelligence algorithms, is able to diagnose cardiovascular diseases.
The proposed technology is non-invasive while, at the same time, as accurate as professional instrumentation. It is simple to use because it does not require medical experience, simply touch the device with a finger to start the acquisition. Finally, it is definitely low-cost when compared with the competitors.
Thanks to the PoC 50000€, 10 prototypes will be assembled and tested in an operational environment on 100 people (TRL 7). Subsequently, it is estimated that another300.000€ will be needed for the innovative startup foundation, the medical certification and produce the first 100 CE certified pieces.